HUE051850T2 - Többszörösen telítetlen zsírsavak 2-hidroxi-származékai, gyógyszerként történõ alkalmazásra - Google Patents

Többszörösen telítetlen zsírsavak 2-hidroxi-származékai, gyógyszerként történõ alkalmazásra

Info

Publication number: HUE051850T2
Authority: HU; Hungary
Prior art keywords: hidroxyderivates; medicaments; fatty acids; polyunsaturated fatty; polyunsaturated
Prior art date: 2009-03-16

Application number

HUE16201132A

Other languages

English (en)

Inventor

Ruiz Pablo Vicente Escriba

Xaubet Xavier Busquets

Jimenez Silvia Teres

Coblijn Gwendolyn Barcelo

Caòellas Victoria Llado

Etxenike Amaia Marcilla

Maria Laura Martin

Urbano Monica Higuera

Martinez Rafael Alvarez

Daniel Horacio Lopez

Castillo Catalina Ana Rosello

Garcia Paula Fernandez

Canalejo Manuel Torres

Original Assignee

Lipopharma Therapeutics S L

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-16

Filing date

2010-03-15

Publication date

2021-03-29

2010-03-15 Application filed by Lipopharma Therapeutics S L filed Critical Lipopharma Therapeutics S L

2021-03-29 Publication of HUE051850T2 publication Critical patent/HUE051850T2/hu

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Physiology (AREA)
Nutrition Science (AREA)
Emergency Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HUE16201132A 2009-03-16 2010-03-15 Többszörösen telítetlen zsírsavak 2-hidroxi-származékai, gyógyszerként történõ alkalmazásra HUE051850T2 (hu)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
ES200900725A ES2345241B1 (es)	2009-03-16	2009-03-16	Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.

Publications (1)

Publication Number	Publication Date
HUE051850T2 true HUE051850T2 (hu)	2021-03-29

Family

ID=42673244

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
HUE16201132A HUE051850T2 (hu)	2009-03-16	2010-03-15	Többszörösen telítetlen zsírsavak 2-hidroxi-származékai, gyógyszerként történõ alkalmazásra
HUE10753158A HUE032027T2 (hu)	2009-03-16	2010-03-15	Politelítetlen zsírsavszármazékok gyógyszerként történõ alkalmazása

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
HUE10753158A HUE032027T2 (hu)	2009-03-16	2010-03-15	Politelítetlen zsírsavszármazékok gyógyszerként történõ alkalmazása

Country Status (19)

Country	Link
US (7)	US9161928B2 (hu)
EP (2)	EP2409963B1 (hu)
JP (1)	JP5904592B2 (hu)
KR (4)	KR101833772B1 (hu)
CN (4)	CN109999018A (hu)
AU (6)	AU2010224749B2 (hu)
BR (1)	BRPI1009860A8 (hu)
CA (1)	CA2754963C (hu)
CL (1)	CL2011002268A1 (hu)
DK (2)	DK2409963T3 (hu)
ES (3)	ES2345241B1 (hu)
HK (1)	HK1232207A1 (hu)
HU (2)	HUE051850T2 (hu)
MX (1)	MX2011009614A (hu)
PL (1)	PL2409963T3 (hu)
PT (2)	PT2409963T (hu)
RU (1)	RU2513995C2 (hu)
SI (1)	SI3159329T1 (hu)
WO (1)	WO2010106211A1 (hu)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2345241B1 (es)	2009-03-16	2011-09-08	Lipopharma Therapeutics	Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
CA2777827C (en)	2009-10-30	2020-08-18	Retrotope, Inc.	Alleviating oxidative stress disorders with pufa derivatives
KR102111997B1 (ko) *	2011-04-26	2020-05-18	레트로토프 인코포레이티드	Ｐｕｆａ와 관련된 신경퇴행성 질환 및 근육 질환
CA2834343C (en)	2011-04-26	2021-10-12	Retrotope, Inc.	Disorders implicating pufa oxidation
JP6106158B2 (ja)	2011-04-26	2017-03-29	レトロトップ、インコーポレイテッドＲｅｔｒｏｔｏｐｅ，Ｉｎｃ．	酸化的網膜疾患
WO2012148927A2 (en)	2011-04-26	2012-11-01	Retrotope, Inc.	Impaired energy processing disorders and mitochondrial deficiency
ES2401629B1 (es) *	2011-10-07	2014-03-04	Universitat De Les Illes Balears	Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos.
CN107428671B (zh)	2014-10-21	2020-12-04	巴利阿里群岛大学	用于合成羟基-三甘油酯的方法及其用于预防和治疗疾病的用途
US20180024150A1 (en) *	2015-03-06	2018-01-25	Niigata University	Biomarker of dementia with lewy bodies
CN108698987B (zh)	2015-11-23	2021-07-13	乐巢拓普有限公司	1,4-二烯体系的位点特异性同位素标记
GB201521085D0 (en) *	2015-11-30	2016-01-13	Biozep As	Use
WO2018210830A1 (en)	2017-05-16	2018-11-22	Ability Pharmaceuticals S.L.	A pharmaceutical combination for the treatment of a cancer
WO2019157516A1 (en)	2018-02-12	2019-08-15	resTORbio, Inc.	Combination therapies
LT3813946T (lt)	2018-06-15	2024-07-10	Janssen Pharmaceutica Nv	Rapamicino analogai ir jų panaudojimas
CN115209897A (zh)	2019-12-05	2022-10-18	安纳库利亚治疗公司	雷帕霉素类似物及其用途
US20230097753A1 (en) *	2020-01-29	2023-03-30	Universitat De Les Illes Balears	Alpha-hydroxylated fatty-acid metabolites, medical uses and use as biomarkers
ES2846824B2 (es) *	2020-01-29	2022-01-19	Univ Illes Balears	Profarmacos de acidos grasos poliinsaturados y usos medicos de los mismos
EP4103170A1 (en)	2020-02-10	2022-12-21	Ability Pharmaceuticals S.L.	A pharmaceutical combination for the treatment of a cancer
KR20220143931A (ko)	2020-02-21	2022-10-25	레트로토프 인코포레이티드	고도불포화 지방산 및 이의 유도체의 동위원소 변형을 위한 공정
US12109194B2 (en)	2021-02-05	2024-10-08	Biojiva Llc	Synergistic combination therapy for treating ALS

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8717816D0 (en)	1987-07-28	1987-09-03	Manchester Inst Science Tech	Fabric testing apparatus
GB2218984B (en) *	1988-05-27	1992-09-23	Renafield Limited	Process for preparing high-concentration mixtures of polyunsaturated fatty acids & their esters and their prophylactic or therapeutic uses
JPH05974A (ja) *	1991-06-21	1993-01-08	Sagami Chem Res Center	ハロゲン化不飽和アルキル化合物及びその前駆体
ES2161146B1 (es) *	1999-06-29	2002-07-01	Consejo Superior Investigacion	Compuestos antimicrobianos, uso y metodo para inducir resistencia a infecciones de bacterias en plantas.
US6344574B1 (en) *	2000-07-20	2002-02-05	The United States Of America As Represented By The Secretary Of Agriculture	Solvent fractionation of chicken fat for making lipid compositions enriched in unsaturated fatty acid-containing triacylglycerols
DE10106660A1 (de) *	2001-02-12	2002-08-29	Celanese Ventures Gmbh	Verfahren zur Herstellung von gamma-Linolensäure aus einer Ciliaten-Kultur durch Zusatz geeigneter Vorläufermoleküle zu dem Kulturmedium
ES2186576B1 (es) *	2001-10-11	2004-09-16	Universitat De Les Illes Balears	Acido 2-hidroxioleico para utilizar como medicamento.
AU2003260687A1 (en) *	2002-04-01	2003-10-20	University Of Southern California	Trihydroxy polyunsaturated eicosanoids
US7135575B2 (en) *	2003-03-03	2006-11-14	Array Biopharma, Inc.	P38 inhibitors and methods of use thereof
US7884131B2 (en)	2004-11-19	2011-02-08	Martek Biosciences, Corporation	Oxylipins from long chain polyunsaturated fatty acids and methods of making and using the same
GB0428384D0 (en)	2004-12-24	2005-02-02	Sla Pharma Ag	Eicosapentaenoic acid
US8324276B2 (en) *	2005-01-24	2012-12-04	Pronova Biopharma Norge As	Fatty acid composition for treatment of alzheimer's disease and cognitive dysfunction
EP1888728A4 (en) *	2005-05-04	2010-07-14	Pronova Biopharma Norge As	Fatty acid analogues, D.H. DHA DERIVATIVES FOR USE AS A MEDICAMENT
CN101213281B (zh) *	2005-05-04	2013-03-13	普罗诺瓦生物医药挪威公司	新的dha衍生物及其作为药物的用途
US8059805B2 (en) *	2005-06-30	2011-11-15	Emc Corporation	Enhanced services provided using communication redirection and processing
AU2006269405B2 (en) *	2005-07-08	2013-01-17	Dsm Ip Assets B.V.	Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
EP1772146A1 (en)	2005-10-03	2007-04-11	Neuropharma, S.A.	Polyunsaturated fatty acids as bace inhibitors
WO2007058523A1 (en) *	2005-11-17	2007-05-24	N.V. Nutricia	Composition with docosapentaenoic acid
ES2366034T3 (es)	2005-12-23	2011-10-14	N.V. Nutricia	Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia.
JP5552313B2 (ja) *	2006-11-01	2014-07-16	プロノヴァ・バイオファーマ・ノルゲ・アーエス	脂質化合物
BRPI0717883A2 (pt)	2006-11-01	2013-10-29	Pronova Biopharma Norge As	Compostos lipídicos, composição contendo os mesmos e uso dos referidos compostos
WO2008053340A1 (en) *	2006-11-03	2008-05-08	Pronova Biopharma Norge As	A combination product comprising at least one lipid substituted in the alpha position and at least one hypoglycemic agent
US20080234377A1 (en) *	2007-03-23	2008-09-25	Martek Biosciences Corporation	Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
ES2345241B1 (es)	2009-03-16	2011-09-08	Lipopharma Therapeutics	Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
ES2401629B1 (es) *	2011-10-07	2014-03-04	Universitat De Les Illes Balears	Enantiómeros de 2-hidroxiderivados de ácidos grasos y su uso como medicamentos.

2009
- 2009-03-16 ES ES200900725A patent/ES2345241B1/es active Active
2010
- 2010-03-15 AU AU2010224749A patent/AU2010224749B2/en not_active Revoked
- 2010-03-15 WO PCT/ES2010/070153 patent/WO2010106211A1/es active Application Filing
- 2010-03-15 ES ES10753158.4T patent/ES2613606T3/es active Active
- 2010-03-15 PL PL10753158T patent/PL2409963T3/pl unknown
- 2010-03-15 KR KR1020117024210A patent/KR101833772B1/ko active IP Right Grant
- 2010-03-15 SI SI201032041T patent/SI3159329T1/sl unknown
- 2010-03-15 JP JP2012500281A patent/JP5904592B2/ja active Active
- 2010-03-15 CN CN201910095352.2A patent/CN109999018A/zh active Pending
- 2010-03-15 CN CN201610773061.0A patent/CN106349058B/zh active Active
- 2010-03-15 CN CN201610773030.5A patent/CN106420686B/zh active Active
- 2010-03-15 KR KR1020187005245A patent/KR20180021931A/ko not_active Application Discontinuation
- 2010-03-15 HU HUE16201132A patent/HUE051850T2/hu unknown
- 2010-03-15 BR BRPI1009860A patent/BRPI1009860A8/pt not_active Application Discontinuation
- 2010-03-15 PT PT107531584T patent/PT2409963T/pt unknown
- 2010-03-15 CA CA2754963A patent/CA2754963C/en active Active
- 2010-03-15 DK DK10753158.4T patent/DK2409963T3/en active
- 2010-03-15 RU RU2011141850/04A patent/RU2513995C2/ru active
- 2010-03-15 DK DK16201132.4T patent/DK3159329T3/da active
- 2010-03-15 CN CN2010800119398A patent/CN102356057A/zh active Pending
- 2010-03-15 KR KR1020207005917A patent/KR102233102B1/ko active IP Right Grant
- 2010-03-15 MX MX2011009614A patent/MX2011009614A/es active IP Right Grant
- 2010-03-15 ES ES16201132T patent/ES2820025T3/es active Active
- 2010-03-15 KR KR1020197004239A patent/KR20190018754A/ko active Search and Examination
- 2010-03-15 PT PT162011324T patent/PT3159329T/pt unknown
- 2010-03-15 HU HUE10753158A patent/HUE032027T2/hu unknown
- 2010-03-15 EP EP10753158.4A patent/EP2409963B1/en active Active
- 2010-03-15 US US13/257,128 patent/US9161928B2/en active Active
- 2010-03-15 EP EP16201132.4A patent/EP3159329B1/en active Active
2011
- 2011-09-13 CL CL2011002268A patent/CL2011002268A1/es unknown
2015
- 2015-09-29 US US14/869,080 patent/US9763907B2/en active Active
- 2015-09-29 US US14/869,045 patent/US9763906B2/en active Active
2016
- 2016-07-13 US US15/209,540 patent/US9907772B2/en active Active
- 2016-10-07 AU AU2016238970A patent/AU2016238970B2/en not_active Revoked
2017
- 2017-06-02 HK HK17105487.0A patent/HK1232207A1/zh unknown
- 2017-08-22 US US15/683,379 patent/US10201515B2/en active Active
2018
- 2018-06-05 AU AU2018203976A patent/AU2018203976B2/en not_active Expired - Fee Related
- 2018-12-18 US US16/224,262 patent/US20190365690A1/en not_active Abandoned
2019
- 2019-09-06 AU AU2019226257A patent/AU2019226257B2/en active Active
2020
- 2020-04-22 US US16/855,463 patent/US11253497B2/en active Active
- 2020-07-13 AU AU2020205214A patent/AU2020205214B2/en active Active
- 2020-07-13 AU AU2020205213A patent/AU2020205213B2/en active Active

Also Published As

Publication number	Publication date
US9907772B2 (en)	2018-03-06
SI3159329T1 (sl)	2021-01-29
EP2409963A1 (en)	2012-01-25
AU2019226257A1 (en)	2019-09-26
US20180085332A1 (en)	2018-03-29
AU2016238970A1 (en)	2016-11-03
US20160158180A1 (en)	2016-06-09
CA2754963C (en)	2022-02-08
ES2613606T3 (es)	2017-05-24
KR101833772B1 (ko)	2018-03-02
US20120108550A1 (en)	2012-05-03
JP5904592B2 (ja)	2016-04-13
CN106420686A (zh)	2017-02-22
RU2513995C2 (ru)	2014-04-27
HK1232207A1 (zh)	2018-01-05
CN102356057A (zh)	2012-02-15
CN109999018A (zh)	2019-07-12
RU2011141850A (ru)	2013-04-27
EP3159329A1 (en)	2017-04-26
AU2019226257B2 (en)	2020-05-07
CN106420686B (zh)	2020-05-22
DK3159329T3 (da)	2020-11-09
AU2010224749A1 (en)	2011-10-13
DK2409963T3 (en)	2017-02-27
US20170035720A1 (en)	2017-02-09
EP2409963B1 (en)	2017-01-04
CA2754963A1 (en)	2010-09-23
MX2011009614A (es)	2012-01-20
CN106349058A (zh)	2017-01-25
KR20200024953A (ko)	2020-03-09
WO2010106211A1 (es)	2010-09-23
CN106349058B (zh)	2020-01-14
AU2020205213A1 (en)	2020-07-30
ES2820025T3 (es)	2021-04-19
AU2016238970B2 (en)	2018-03-08
US20160158181A1 (en)	2016-06-09
ES2345241B1 (es)	2011-09-08
AU2020205213B2 (en)	2021-02-25
US20200352891A1 (en)	2020-11-12
US11253497B2 (en)	2022-02-22
AU2010224749B2 (en)	2016-07-07
KR20110137365A (ko)	2011-12-22
BRPI1009860A8 (pt)	2019-12-17
AU2018203976A1 (en)	2018-06-21
AU2020205214B2 (en)	2021-02-18
CL2011002268A1 (es)	2012-01-27
PT3159329T (pt)	2020-11-13
KR102233102B1 (ko)	2021-03-26
US9763906B2 (en)	2017-09-19
PT2409963T (pt)	2017-02-15
US20190365690A1 (en)	2019-12-05
BRPI1009860A2 (pt)	2016-03-08
EP3159329B1 (en)	2020-08-12
ES2345241A1 (es)	2010-09-17
KR20180021931A (ko)	2018-03-05
KR20190018754A (ko)	2019-02-25
US10201515B2 (en)	2019-02-12
US9161928B2 (en)	2015-10-20
US9763907B2 (en)	2017-09-19
JP2012520344A (ja)	2012-09-06
HUE032027T2 (hu)	2017-08-28
EP2409963A4 (en)	2013-10-02
AU2020205214A1 (en)	2020-07-30
AU2018203976B2 (en)	2019-06-06
PL2409963T3 (pl)	2017-05-31

Publication	Publication Date	Title
HK1232207A1 (zh)	2018-01-05	多不飽和脂肪酸的衍生物作為藥物的用途
EP2498602A4 (en)	2014-05-21	STABILIZED FORMULATIONS FROM FATTY ACIDS
EP2459189A4 (en)	2013-01-16	FATTY ACIDS AS ANTI-INFLAMMATORY ACTIVE SUBSTANCES
EP2425007A4 (en)	2013-01-02	PREPARATION OF FATTY ACID ESTERS
IL212112A0 (en)	2011-06-30	Production of modifird fatty acids in plants
EP2521447A4 (en)	2014-04-30	FATTY FATTY ACID DERIVATIVES AND USES THEREOF
EP2483233A4 (en)	2013-08-14	HETEROATOMA CONTAINING SUBSTITUTED FATTY ACIDS
ZA201104036B (en)	2012-03-28	Fatty acids for use as a medicament
IL232748A0 (en)	2014-07-31	Preparations including fatty acids with 20 carbons and methods for their preparation and use
IL213354A (en)	2017-06-29	Alpha-monoclonal fatty acid alpha history for use as a drug
HUE041867T2 (hu)	2019-06-28	Eljárás zsírsavak elõállítására és tisztítására
IL214887A0 (en)	2011-11-30	Fatty acid monoglyceride compositions
GB201304550D0 (en)	2013-04-24	Conjugates of polyunsaturated fatty acids and amine-containing compounds and uses thereof
EP2726086A4 (en)	2015-04-29	COMPOSITIONS CONTAINING FATTY NITROACIDS
IL219958A0 (en)	2012-07-31	Omega-3 fatty acid enriched meat compositions
HK1185806A1 (zh)	2014-02-28	含有多不飽和脂肪酸的組合物
GB0904300D0 (en)	2009-04-22	Essential fatty acid compounds
AU2010903057A0 (en)	2010-07-22	Acetylenation of fatty acids
GB201021862D0 (en)	2011-02-02	Improvements in the manufacture of fatty acids